Keywords: ligand, buy, down, lilly, ontak, royalties, pharmaceuticals

Ligand to buy down Lilly Ontak royalties

Article | 17 January 2005

Print This

Ligand Pharmaceuticals, which acquired the US rights to the cancer drug Ontak (denileukin diftitox) from Eli Lilly in 1997 in a $67 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in